INCYTE CORPORATION Fair Value, Assets, Level 2 to Level 1 Transfers, Amount
INCYTE CORPORATION (INCY) had Fair Value, Assets, Level 2 to Level 1 Transfers, Amount of $0 as of 2019-12-31, per its 10-K filed 2020-02-13.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:FairValueAssetsLevel2ToLevel1TransfersAmount · last filed 2020-02-13
- 2019-12-31: Fair Value, Assets, Level 2 to Level 1 Transfers, Amount $0.00.
- 2019-09-30: Fair Value, Assets, Level 2 to Level 1 Transfers, Amount $0.00.
- 2019-06-30: Fair Value, Assets, Level 2 to Level 1 Transfers, Amount $0.00.
- 2019-03-31: Fair Value, Assets, Level 2 to Level 1 Transfers, Amount $0.00.
| Period end | Fair Value, Assets, Level 2 to Level 1 Transfers, Amount |
|---|---|
| 2019-12-31 | $0.00 10-K · filed 2020-02-13 |
| 2019-09-30 | $0.00 10-Q · filed 2019-10-29 |
| 2019-06-30 | $0.00 10-Q · filed 2019-07-30 |
| 2019-03-31 | $0.00 10-Q · filed 2019-04-30 |
| 2018-12-31 | $0.00 10-K · filed 2019-02-14 |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-01 |
| 2017-09-30 | $78.30M 10-Q · filed 2017-10-31 |
| 2017-06-30 | $50.70M 10-Q · filed 2017-08-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |